Iris M. Goldstein

Dose escalation of osimertinib for intracranial progression in EGFR mutated non-small-cell lung cancer with brain metastases

Iris M. Goldstein, Laila C. Roisman, Shoshana Keren-Rosenberg et al. · Neuro-Oncology Advances · 2020 · 27 citations · Full text

Medicine, Oncology, Pharmacology +17

The impact of osimertinib’ line on clonal evolution in EGFRm NSCLC through NGS-based liquid biopsy and overcoming strategies for resistance

Vered Fuchs, Laila C. Roisman, Waleed Kian et al. · Lung Cancer · 2021 · 26 citations

Medicine, Molecular Biology, Pharmacology +17

Osimertinib in advanced EGFR-mutant lung adenocarcinoma with asymptomatic brain metastases: an open-label, 3-arm, phase II pilot study

Nir Peled, Waleed Kian, Edna Inbar et al. · Neuro-Oncology Advances · 2021 · 23 citations · Full text

Medicine, Oncology, Pharmacology +17

Vismodegib as First-Line Treatment of Mutated Sonic Hedgehog Pathway in Adult Medulloblastoma

Waleed Kian, Laila C. Roisman, Iris M. Goldstein et al. · JCO Precision Oncology · 2020 · 14 citations · Full text

Medicine, Oncology, Pharmacology +17

Bevacizumab for stereotactic radiosurgery-induced radiation necrosis in patients with non-small cell lung cancer treated with immune check-point inhibitors

Assaf Moore, Shlomit Yust‐Katz, Oded Icht et al. · Journal of the Neurological Sciences · 2021 · 12 citations

Medicine, Oncology, Radiation Oncology +14